These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12076255)

  • 1. T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects.
    Axdorph U; Porwit-Macdonald A; Sjøberg J; Grimfors G; Bjørkholm M
    APMIS; 2002 May; 110(5):379-90. PubMed ID: 12076255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease.
    Axdorph U; Porwit-MacDonald A; Grimfors G; Björkholm M
    Leuk Lymphoma; 2001; 42(5):1055-65. PubMed ID: 11697623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.
    Alvaro-Naranjo T; Lejeune M; Salvadó-Usach MT; Bosch-Príncep R; Reverter-Branchat G; Jaén-Martínez J; Pons-Ferré LE
    Leuk Lymphoma; 2005 Nov; 46(11):1581-91. PubMed ID: 16236613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
    Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK
    Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
    Felgar RE; Steward KR; Cousar JB; Macon WR
    Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
    Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
    Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
    Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
    Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
    Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
    Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma.
    Bosch Príncep R; Lejeune M; Salvadó Usach MT; Jaén Martínez J; Pons Ferré LE; Alvaro Naranjo T
    Ann Hematol; 2005 Oct; 84(10):661-6. PubMed ID: 15875183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B.
    Morice WG; Kurtin PJ; Tefferi A; Hanson CA
    Blood; 2002 Jan; 99(1):268-74. PubMed ID: 11756181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
    Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
    Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunophenotype and differential diagnosis of Hodgkin's lymphoma].
    Liu Y; Zhuang H; Liao X; Luo X; Luo D; Cai X
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):524-7. PubMed ID: 12482349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
    Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
    Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
    McBride JA; Rodriguez J; Luthra R; Ordóñez NG; Cabanillas F; Pugh WC
    Am J Surg Pathol; 1996 Feb; 20(2):193-201. PubMed ID: 8554109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.